Literature DB >> 30527271

An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia.

P A McArdle1, V De Mel2, V DeMonte2, K Winckel3, V Gore-Jones2, S Foley2, N Korman2, S Parker4, F Dark4, D Siskind5.   

Abstract

Entities:  

Keywords:  Anti-cholinergic; Clozapine; Cognition; Cognitive; Psychosis; Schizoaffective; Schizophrenia

Mesh：

Substances：

Year:  2018        PMID： 30527271     DOI： 10.1016/j.schres.2018.11.030

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  Effects of Clozapine on Neurocognitive Functions in Schizophrenia: A Naturalistic Comparison to Non-clozapine Antipsychotics.

Authors:  J P Lindenmayer; Beverly J Insel; Anzalee Khan; McKenzie Osborne; Abraham Goldring; Mary Seddo
Journal:  Innov Clin Neurosci       Date:  2021 Oct-Dec

Review 2.  Targeting muscarinic receptors to treat schizophrenia.

Authors:  Daniel J Foster; Zoey K Bryant; P Jeffrey Conn
Journal:  Behav Brain Res       Date:  2021-02-26       Impact factor: 3.332

3.  Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia.

Authors:  Kenya A Costa-Dookhan; Tarek K Rajji; Veronica N Tran; Sylvie Bowden; Daniel J Mueller; Gary J Remington; Sri Mahavir Agarwal; Margaret K Hahn
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.